EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study)

Atthaphong Phongphithakchai, Rinaldo Bellomo, Peter Mount, Cindy-Anne T Bach, Greta Gurry, Wendy Liu, Akinori Maeda, Nuttapol Pattamin, Yukiko Hikasa, Sofia Spano, Anis Chaba, Glenn Eastwood und 4 weitere

American Journal of Nephrology · 2025

DOI: 10.1159/000543280 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Atthaphong Phongphithakchai und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia, ton331@hotmail.com. Hauptthemen laut MEDLINE: Angiotensin II, Renal Dialysis, Muscle Cramp, Kidney Failure, Chronic. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Angiotensin II may reduce muscle ischemia during intermittent hemodialysis (IHD) and thereby decrease the incidence and/or intensity of intradialytic muscle cramps. We aimed to test whether angiotensin II infusion during IHD is safe, feasible, and effective in the attenuation of muscle cramps.

Methods

We performed a pilot, single-blinded, randomized crossover trial of patients receiving IHD who frequently experience intradialytic muscle cramps. Patients were randomly allocated to receive either intravenous angiotensin II or placebo for the duration of their first dialysis session of the week. They crossed over to the alternate arm each week for 4 weeks. The primary outcome was safety. Secondary outcomes included cramp-related symptoms, hemodynamic parameters, dialysis prescription alterations, and biomarkers.

Results

We studied 24 sessions in 6 patients. Intradialytic hypertension (systolic blood pressure >180 mm Hg) occurred more often with angiotensin II than with placebo (4/12 sessions, 33% vs. 2/12 sessions, 17% sessions, p = 0.64). There were no other adverse events. Compared with placebo, muscle cramps were less frequent (4/12 sessions, 33% vs. 11/12 sessions, 92% sessions, p = 0.009) and of lower intensity with angiotensin II (median Brief Pain Inventory score 1.4 vs. 5.3; p < 0.001; maximal Brief Pain Inventory score 1.2 vs. 6.0; p < 0.001). Fluid bolus administration for cramps was less common during angiotensin II infusion than placebo (0/12 sessions, 0% vs. 5/12 sessions, 42% sessions, p = 0.037).

Conclusion

Angiotensin II increased blood pressure and heart rate but not cardiac output or levels of troponin, creatine kinase, or renin. Angiotensin II infusion during IHD appears safe and effective at reducing intradialytic muscle cramps. These observations justify further investigation in larger controlled studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Angiotensin IIRenal DialysisMuscle CrampKidney Failure, ChronicVasoconstrictor AgentsHumansMaleFemaleCross-Over StudiesPilot ProjectsMiddle AgedSingle-Blind MethodAgedTreatment Outcome

Stichwörter der Autor:innen

Angiotensin IIBlood pressureCrampsHemodialysisRenin

Substanzen

Angiotensin IIVasoconstrictor Agents

Autor:innen und Institutionen

  • Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia, ton331@hotmail.com.
  • Division of Nephrology, Department of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand, ton331@hotmail.com.
  • Department of Intensive Care, Austin Hospital, Melbourne, Victoria, Australia.
  • Department of Critical Care, The University of Melbourne, Melbourne, Victoria, Australia.
  • Department of Intensive Care, Royal Melbourne Hospital, Parkville, Victoria, Australia.
  • Australian and New Zealand Intensive Care Research Centre, Monash University, Melbourne, Victoria, Australia.

Zitieren

APA

Phongphithakchai, A., Bellomo, R., Mount, P., Bach, C. T., Gurry, G., Liu, W., Maeda, A., Pattamin, N., Hikasa, Y., Spano, S., Chaba, A., Eastwood, G., Chawla, M., Atkinson, A. J., Wilkie, J., & See, E. J. (2025). A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study). American Journal of Nephrology. https://doi.org/10.1159/000543280

Vancouver

Phongphithakchai A, Bellomo R, Mount P, Bach CT, Gurry G, Liu W, et al. A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study). American Journal of Nephrology. 2025. doi:10.1159/000543280

BibTeX
@article{Phongphithakchai2025,
  author = {Phongphithakchai, Atthaphong and Bellomo, Rinaldo and Mount, Peter and Bach, Cindy-Anne T and Gurry, Greta and Liu, Wendy and Maeda, Akinori and Pattamin, Nuttapol and Hikasa, Yukiko and Spano, Sofia and Chaba, Anis and Eastwood, Glenn and Chawla, Mink and Atkinson, Arthur J and Wilkie, James and See, Emily J},
  title = {A Pilot, Single-Blinded, Randomized Crossover Trial of Cramp Reduction with Angiotensin II in Maintenance Patients on Hemodialysis (the CRAMP-HD Study)},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000543280}
}
Kostenlos starten →